KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Total Debt (2020 - 2025)

Supernus Pharmaceuticals has reported Total Debt over the past 9 years, most recently at $31.1 million for Q4 2025.

  • Quarterly Total Debt fell 34.41% to $31.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.1 million through Dec 2025, down 34.41% year-over-year, with the annual reading at $31.1 million for FY2025, 34.41% down from the prior year.
  • Total Debt was $31.1 million for Q4 2025 at Supernus Pharmaceuticals, up from $11.2 million in the prior quarter.
  • Over five years, Total Debt peaked at $424.1 million in Q4 2021 and troughed at $11.2 million in Q3 2025.
  • The 5-year median for Total Debt is $46.2 million (2023), against an average of $77.9 million.
  • The largest YoY upside for Total Debt was 1603.17% in 2022 against a maximum downside of 95.02% in 2022.
  • A 5-year view of Total Debt shows it stood at $424.1 million in 2021, then plummeted by 95.02% to $21.1 million in 2022, then soared by 146.54% to $52.1 million in 2023, then dropped by 9.08% to $47.3 million in 2024, then plummeted by 34.41% to $31.1 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Total Debt are $31.1 million (Q4 2025), $11.2 million (Q3 2025), and $30.0 million (Q1 2025).